Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Relationship of the hs-CRP Levels with FBG, Fructosamine, and HbA1c in Non-diabetic Obesity Adults

당뇨병이 없는 비만 성인의 hs-CRP 수준과 FBG, Fructosamine 및 HbA1c와의 관련성

  • Oh, Hye Jong (Department of Biomedical Laboratory Science, Hanlyo University) ;
  • Choi, Cheol Won (Department of Biomedical Laboratory Science, Hanlyo University)
  • 오혜종 (한려대학교 임상병리학과) ;
  • 최철원 (한려대학교 임상병리학과)
  • Received : 2018.04.09
  • Accepted : 2018.04.29
  • Published : 2018.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Obesity has been reported to be a cluster of risk factors in the pathological ecology, In particular, there is increasing evidence that inflammation-related factors are associated with diabetes. This study examined the relationship between the hs-CRP level and FBG, fructosamine, and $HbA_1c$ in 4,734 non-diabetic adults aged 20 years or older, who were approved by the National Health and Nutrition Survey in 2015. The results showed that the FBG, fructosamine, and $HbA_1c$ levels increased with increasing BMI; the hs-CRP levels were the highest in the obese group, and HOMA-IR, an index of insulin resistance, was also significantly higher in the obese group. The hs-CRP level was the highest in obese adults. The levels of FBG, fructosamine. and $HbA_1c$, which are involved in blood glucose control, increased with increasing hs-CRP level. The FBG, fructosamine, and $HbA_1c$ levels increased significantly with increasing hs-CRP level after adjusting for various related variables. These results suggest that the obesity-induced increase in hs-CRP is a risk factor for diabetes mellitus in non-diabetic adults. Therefore, proper dietary habits and regular exercise should prevent diabetes by preventing obesity in non-diabetic adults.

본 연구는 국민건강영양조사 자료를 이용하여 당뇨병이 없는 성인 4,734명을 대상으로 비만 성인의 hs-CRP와 혈당조절 지표들과의 관련성에 대해 알아보고자 하였다. 연구결과 BMI가 증가할수록 혈당조절지표인 FBG와 fructosamine 및 $HbA_1c$가 증가하였으며, hs-CRP는 비만 군에서 가장 높은 수치를 보였고, 인슐린저항성의 지표인 HOMA-IR도 비만 군에서 통계적으로 유의하게 증가하였다. 또한 hs-CRP 수준을 구분하여 혈당조절지표들과의 관련성을 확인한 결과 hs-CRP가 증가할수록 FBG, fructosamine 및 $HbA_1c$가 증가됨을 확인하였고, 여러 관련 변수를 보정한 후에도 hs-CRP가 증가할수록 FBG, fructosamine 및 $HbA_1c$가 통계적으로 유의하게 증가하였다. 결과적으로 비만과 hs-CRP, 혈당조절지표는 각각에서 연관성을 보여 당뇨병이 없는 성인 중 높은 BMI에서 증가된 hs-CRP에 의해 당뇨병의 주요한 병인인 인슐린 저항성을 증가시켜 혈당조절지표인 FBG, fructosamine 및 $HbA_1c$가 통계적으로 유의하게 증가한 것으로 사료된다. 이에 당뇨병이 없는 성인에서도 올바른 식습관 및 규칙적인 운동으로 비만을 예방하여 당뇨병 발생을 감소시키는 노력이 강구되어야 하겠다.

Keywords

References

  1. Welborn TA, Knuiman MW, Vu HT. Body mass index and alternative indices of obesity in relation to height, triceps skinfold and subsequent mortality: the Busselton health study. Int J Obes Relat Metab Disord. 2000;24:108-115. https://doi.org/10.1038/sj.ijo.0801093
  2. Carlsson S, Ahlbom A, Lichtenstein P, Andersson T. Shared genetic influence of BMI, physical activity and type 2 diabetes: a twin study. Diabetologia. 2013;56:1031-1035. doi: 10.1007/s00125-013-2859-3.
  3. Scragg R, Sowers M, Bell C, Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27:2813-2818. https://doi.org/10.2337/diacare.27.12.2813
  4. International Diabetes Federation. IDF diabetes atlas, Sixth edition in chapter 2 the global burden. Basel, Switzerland, International Diabetes Federation 2013;6:29-49, http://hdl.handle.net/10536/DRO/DU:30060687.
  5. Ministry of Health and Welfare, Korea Health Statistics 2016: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Report. Seoul: Korea Centers for Disease Control and Prevention; 2017.
  6. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(Suppl 1):11-61. doi: 10.2337/dc10-S011.
  7. Di Mauro M, Lazzarini D, Fumelli P, Carle F, Kosmidis A. Bioelectrical impedance analysis and diabetes mellitus: which correlation among fructosamine, glycosylated haemoglobin and exchangeable potassium. Minerva Med. 2007;98:633-638.
  8. Krishnamurti U, Steffes MW. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem. 2001;47:1157-1165. https://doi.org/10.1093/clinchem/47.7.1157
  9. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, et al. Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract. 2004;64:99-106. https://doi.org/10.1016/j.diabres.2003.10.007
  10. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 1999;84:1018-1022. https://doi.org/10.1016/S0002-9149(99)00491-9
  11. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol. 2001;88:1264-1269. https://doi.org/10.1016/S0002-9149(01)02088-4
  12. Hong AR, Lee KS, Lee SY, Yu JH. Association of current and past smoking with metabolic syndrome in men. J Prev Med Public Health. 2009;42:160-164. https://doi.org/10.3961/jpmph.2009.42.3.160
  13. Madsen C, Nafstad P, Eikvar L, Schwarze PE, Ronningen KS, Haaheim LL. Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II Study. Eur J Epidemiol. 2007;22:311-317. https://doi.org/10.1007/s10654-007-9121-6
  14. Ministry of Health and Welfare, Korea Health Statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3). Report. Seoul: Korea Centers for Disease Control and Prevention; 2016.
  15. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clinic Proc. 2011;86:50-60. doi: 10.4065/mcp.2010.0567.
  16. Jung HK. Clinical chemistry II. 2nd ed. Seoul: Chung Ku Publisher; 2015. p40-41.
  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. https://doi.org/10.1007/BF00280883
  18. Carlsson S, Ahlbom A, Lichtenstein P, Andersson T. Shared genetic influence of BMI, physical activity and type 2 diabetes: a twin study. Diabetologia. 2013;56:1031-1035. doi: 10.1007/s00125-013-2859-3.
  19. Shin KA. The relationship between metabolic syndrome risk factors and high sensitive C-reactive protein in abdominal obesity elderly women. Korean J Clin Lab Sci. 2017;49:121-127. https://doi.org/10.15324/kjcls.2017.49.2.121.
  20. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-192. doi: 10.1038/nri2254.
  21. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-137. https://doi.org/10.7326/0003-4819-128-2-199801150-00009
  22. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1998-1994. J Pediatr. 2001;138:486-492. https://doi.org/10.1067/mpd.2001.112898
  23. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2002;11:212-217.
  24. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801. https://doi.org/10.1172/JCI29069
  25. Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism. 2002;51:743-749. https://doi.org/10.1053/meta.2002.32804
  26. Festa A Jr. D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42-47. https://doi.org/10.1161/01.CIR.102.1.42
  27. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia. 1998;41:1241-1248. https://doi.org/10.1007/s001250051058
  28. Endo M, Yanagisawa K, Tsuchida K, Okamoto T, Matsushita T, Higuchi M, et al. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm Metab Res. 2001;33:317-322. https://doi.org/10.1055/s-2001-15122
  29. Sato T, Iwaki M, Shimogaito N, Wu XG, Yamagishi S, Takeuchi M. TAGE (toxic AGEs) theory in diabetic complications. Curr Mol Med. 2006;6:351-358. https://doi.org/10.2174/156652406776894536